Summit Therapeutics (SMMT) Interest & Investment Income (2016 - 2020)
Historic Interest & Investment Income for Summit Therapeutics (SMMT) over the last 5 years, with Q1 2020 value amounting to -$1000.0.
- Summit Therapeutics' Interest & Investment Income fell 13840.62% to -$1000.0 in Q1 2020 from the same period last year, while for Mar 2020 it was $5841.4, marking a year-over-year decrease of 9984.45%. This contributed to the annual value of $5000.0 for FY2019, which is N/A changed from last year.
- Per Summit Therapeutics' latest filing, its Interest & Investment Income stood at -$1000.0 for Q1 2020, which was down 13840.62% from $1237.7 recorded in Q4 2019.
- In the past 5 years, Summit Therapeutics' Interest & Investment Income registered a high of $4.1 million during Q4 2017, and its lowest value of -$10625.1 during Q4 2017.
- Moreover, its 5-year median value for Interest & Investment Income was $2000.0 (2016), whereas its average is $491396.6.
- Examining YoY changes over the last 5 years, Summit Therapeutics' Interest & Investment Income showed a top increase of 28315494.27% in 2018 and a maximum decrease of 17008.57% in 2018.
- Quarter analysis of 5 years shows Summit Therapeutics' Interest & Investment Income stood at $2000.0 in 2016, then plummeted by 631.25% to -$10625.1 in 2017, then soared by 1012.93% to $97000.0 in 2018, then tumbled by 98.72% to $1237.7 in 2019, then plummeted by 180.8% to -$1000.0 in 2020.
- Its last three reported values are -$1000.0 in Q1 2020, $1237.7 for Q4 2019, and $2603.7 during Q1 2019.